<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>ADLD | YuanSilencer</title><link>https://yuansilencer.com/tag/adld/</link><atom:link href="https://yuansilencer.com/tag/adld/index.xml" rel="self" type="application/rss+xml"/><description>ADLD</description><generator>Hugo Blox Builder (https://hugoblox.com)</generator><language>en-us</language><lastBuildDate>Wed, 05 Nov 2025 00:00:00 +0000</lastBuildDate><image><url>https://yuansilencer.com/media/icon_hu_7613a4a452ac7087.png</url><title>ADLD</title><link>https://yuansilencer.com/tag/adld/</link></image><item><title>An oligodendrocyte silencer element underlies the pathogenic impact of lamin B1 structural variants</title><link>https://yuansilencer.com/post/25-05-08-3/</link><pubDate>Wed, 05 Nov 2025 00:00:00 +0000</pubDate><guid>https://yuansilencer.com/post/25-05-08-3/</guid><description>&lt;p>A non-coding &lt;strong>silencer&lt;/strong> near &lt;strong>LMNB1&lt;/strong> constrains lamin B1 expression specifically in &lt;strong>oligodendrocytes&lt;/strong> via &lt;strong>CTCF‑mediated looping&lt;/strong> and &lt;strong>PRC2&lt;/strong> recruitment. Loss of this element—through upstream deletions or tandem duplications—drives overexpression and explains the tissue‑specific pathology of &lt;strong>autosomal dominant leukodystrophy (ADLD)&lt;/strong>.&lt;/p>
&lt;h2 id="abstract-concise-summary">Abstract (concise summary)&lt;/h2>
&lt;p>Investigating families with &lt;strong>LMNB1&lt;/strong> tandem duplications that surprisingly &lt;strong>do not&lt;/strong> show demyelination, alongside ADLD tissues, CRISPR‑edited cell lines, and mouse models,
the authors identify an &lt;strong>oligodendrocyte‑specific silencer&lt;/strong>. This element contains &lt;strong>CTCF&lt;/strong> sites that form &lt;strong>3D chromatin loops&lt;/strong> and recruit &lt;strong>PRC2&lt;/strong>, reducing LMNB1 transcription
in oligodendrocytes. &lt;strong>Loss of the silencer&lt;/strong> (by upstream deletion) or &lt;strong>functional uncoupling&lt;/strong> (with certain duplications) elevates LMNB1 expression and underpins ADLD’s
&lt;strong>cell‑type specificity&lt;/strong> and pathogenesis.&lt;/p>
&lt;h2 id="key-takeaways">Key takeaways&lt;/h2>
&lt;ul>
&lt;li>&lt;strong>Mechanism&lt;/strong>: CTCF‑anchored looping plus &lt;strong>PRC2‑mediated repression&lt;/strong> keeps LMNB1 low in oligodendrocytes; removing the element lifts repression.&lt;/li>
&lt;li>&lt;strong>Evidence&lt;/strong>: Multi‑family human genetics, ATAC/ChIP, CRISPR editing, reporter assays, RNA/protein readouts, and &lt;strong>mouse models&lt;/strong> converge on the same mechanism.&lt;/li>
&lt;li>&lt;strong>Clinical lens&lt;/strong>: Explains why LMNB1 dosage changes cause &lt;strong>CNS‑restricted demyelination&lt;/strong>, despite broad LMNB1 expression.&lt;/li>
&lt;li>&lt;strong>Therapeutic angle&lt;/strong>: Restoring the silencer’s function (synthetic silencers/insulators, epigenetic targeting) could normalize LMNB1 in ADLD.&lt;/li>
&lt;/ul>
&lt;h2 id="suggested-citation">Suggested citation&lt;/h2>
&lt;p>Nmezi B, Rodriguez Bey G, DeFrancesco Oranburg T, &lt;em>et al.&lt;/em> &lt;strong>An oligodendrocyte silencer element underlies the pathogenic impact of lamin B1 structural variants.&lt;/strong>
&lt;em>Nat Commun.&lt;/em> 2025;16(1):1373. doi:10.1038/s41467-025-56378-9.&lt;/p></description></item></channel></rss>